Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

What additional medications were you taking at the time?

Was Gemfibrozil (Lopid) taken while taking Baycol?

Has Rhabdomyolysis been diagnosed?

Have any of the following side effects occurred?

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Bayer gets second subpoena over withdrawn Baycol drug

Mar 7, 2006 | AP

Bayer AG disclosed Monday that it received a subpoena from the U.S. attorney for New Jersey relating to its withdrawn Baycol/Cerivastatin anti-cholesterol drug, which has allegedly been linked to about 100 deaths.

Bayer received the subpoena last month, according to the company's annual report filed with the federal Securities and Exchange Commission.

The German-based pharmaceutical and chemical company had received a subpoena in January 2004 also related to its Baycol drug from the Defense Criminal Investigative Service of the U.S. Department of Defense Inspector General.

Bayer withdrew Baycol from the market in August 2001 after it was allegedly linked to about 100 deaths.

The company said that as of Jan. 13, it had paid $1.15 billion to settle 3,082 Baycol cases, without acknowledging any liability.

Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo